Dishman Carbogen Amcis Limited (NSE:DCAL)
India · Delayed Price · Currency is INR 266.00
-3.65 (-1.35%)
Aug 22, 2025, 3:29 PM IST
Dishman Carbogen Amcis Market Cap
Dishman Carbogen Amcis has a market cap or net worth of 42.04 billion as of August 22, 2025. Its market cap has increased by 40.44% in one year.
Market Cap
42.04B
Enterprise Value
60.61B
Revenue
28.96B
Ranking
n/a
PE Ratio
39.72
Stock Price
266.00
Market Cap Chart
Since September 21, 2017, Dishman Carbogen Amcis's market cap has decreased from 56.82B to 42.04B, a decrease of -26.01%. That is a compound annual growth rate of -3.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2025 | 42.28B | -0.31% |
| Dec 31, 2024 | 42.41B | 58.22% |
| Dec 29, 2023 | 26.80B | 80.14% |
| Dec 30, 2022 | 14.88B | -52.91% |
| Dec 31, 2021 | 31.60B | 45.21% |
| Dec 31, 2020 | 21.76B | 59.76% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Sep 21, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 3,902.76B |
| Divi's Laboratories | 1,613.92B |
| Cipla | 1,251.13B |
| Apollo Hospitals Enterprise | 1,124.90B |
| Mankind Pharma | 1,028.60B |
| Zydus Lifesciences | 995.62B |
| Fortis Healthcare | 716.38B |
| Alkem Laboratories | 644.69B |